Related Experiment Video
Updated: Dec 23, 2025

Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Unique Role of Histone Methyltransferase PRDM8 in the Tumorigenesis of Virus-Negative Merkel Cell Carcinoma
Elias Orouji1,2,3, Wiebke K Peitsch2,4, Azadeh Orouji2
1Skin Cancer Unit, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Abstract:
Merkel cell carcinoma (MCC) is a deadly skin cancer, and about 80% of its cases have been shown to harbor integrated Merkel polyomavirus in the tumor cell genome. Viral oncoproteins expressed in the tumor cells are considered as the oncogenic factors of these virus-positive Merkel cell carcinoma (VP-MCC). In contrast, the molecular pathogenesis of virus-negative MCC (VN-MCC) is less well understood. Using gene expression analysis of MCC cell lines, we found histone methyltransferase PRDM8 to be elevated in VN-MCC. This finding was confirmed by immunohistochemical analysis of MCC tumors, revealing that increased PRDM8 expression in VN-MCC is also associated with increased H3K9 methylation. CRISPR-mediated silencing of PRDM8 in MCC cells further supported the histone methylating role of this protein in VN-MCC. We also identified miR-20a-5p as a negative regulator of PRDM8. Taken together, our findings provide insights into the role of PRDM8 as a histone methyltransferase in VN-MCC tumorigenesis.
Insights
Researchers identified histone methyltransferase PRDM8 as a key factor in virus-negative Merkel cell carcinoma (VN-MCC) development. Elevated PRDM8 promotes VN-MCC by increasing H3K9 methylation, offering new insights into this deadly skin cancer.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Merkel cell carcinoma (MCC) is an aggressive skin cancer.
- Virus-positive MCC (VP-MCC) is linked to Merkel polyomavirus oncoproteins.
- The molecular drivers of virus-negative MCC (VN-MCC) remain largely unknown.
Purpose of the Study:
- To investigate the molecular mechanisms underlying VN-MCC pathogenesis.
- To identify potential oncogenic factors in VN-MCC.
- To explore the role of epigenetic regulators in VN-MCC.
Main Methods:
- Gene expression analysis of MCC cell lines.
- Immunohistochemical analysis of MCC tumor samples.
- CRISPR-mediated gene silencing.
- MicroRNA expression analysis.
Main Results:
- Histone methyltransferase PRDM8 expression is elevated in VN-MCC.
- Increased PRDM8 correlates with elevated H3K9 methylation in VN-MCC.
- PRDM8 silencing reduces tumorigenic properties in MCC cells.
- miR-20a-5p acts as a negative regulator of PRDM8.
Conclusions:
- PRDM8 functions as a histone methyltransferase in VN-MCC.
- PRDM8 plays a significant role in VN-MCC tumorigenesis.
- Understanding PRDM8's role may lead to novel therapeutic strategies for VN-MCC.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle

